Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.07

-3.4%

Nov 20 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John O'Neill who wrote (18944)	4/12/1998 11:53:00 AM
From: JOEBT1	Read Replies (2) of 32384

Jo There's lots of news on the horizon for LGND. Panretin NDA in 2Q; TSE424 trials to begin in 2Q; NDA for topical Targretin in 2Q/3Q; LLY compound choice in 2Q; Phase II Targretin breast cancer trial start in 2Q; Results from lung cancer, breast cancer(NCI trial), kidney cancer, prostate cancer,ovarian cancer PhaseII trials in 2Q/3Q; Psoriasis PhaseII in 3Q/4Q; Start of Phase II LLy diabetes in 2Q; etc, etc. All the above gleamed from H&Q, Robertson Stephens reports and other posts.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next